RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

This publication has 13 references indexed in Scilit:

• Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
  Journal of Clinical Oncology, 2005
• Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor Response
  Journal of Clinical Oncology, 2003
• Radiological Measurement of Breast Cancer Metastases to Lung and Liver: Comparison Between WHO (Bidimensional) and RECIST (Unidimensional) Guidelines
  Journal of Computer Assisted Tomography, 2003
• Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria
  The British Journal of Radiology, 2002
• Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial ct scan-based study
  International Journal of Radiation Oncology*Biology*Physics, 2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
  Journal of Clinical Oncology, 1999
• Selection of large and objectively measurable target lesions in EORTC phase II trials: Impact on recruitment and response rate
  European Journal Of Cancer, 1993
• Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
  Investigational New Drugs, 1992
• Reporting results of cancer treatment
  Cancer, 1981